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Abstract. This study was conducted to determine the potential of soy-yamgurt probiotics 
drink from the mixture of yam and soy extract with a ratio of 1: 1 in reducing the fasting 
blood glucose level of rats induced by streptozotocin-nicotinamide. Based on the analysis 
of chemical and phytochemical characteristics of soy-yamgurt, it was found that it has 
water content (80.97%), total solids (18.85%), protein content (11.95%), total lactic acid 
(1.03%), viscosity (20.56 Pa.s), lactic acid bacteria (10.22 log CFU/g), fiber content 
(0.98%), IC50 value (44.99 μg/ml), total phenol (711.90 μgGAE/g) and total flavonoids 
(1345.73 μgQE/g). The in vivo test used thirty 10-16 week old male Wistar rats with an 
average weight of 160-200 g divided into 5 groups: P1 (control), P2 (streptozotocin-
nicotinamide), P3 (glibenclamide of 0.45 mg/kg body weight), P4 (3 ml of soy-yamgurt) and 
P5 (3.5 ml of soy-yamgurt).The results showed that the soy-yamgurt at the doses of 3 
ml/160 g body weight and 3.5 ml/160 g body weight for 4 weeks in streptozotocin-
nicotinamide-induced rats had significantly (P<0.01) lowered blood glucose levels and 
increased their weight. 
Keywords: antioxidant activity, diabetes mellitus, soy milk, soy-yamgurt, streptozotocin 
nicotinamide  
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1. Introduction 
Diabetes mellitus (DM) has become one of the major health problems. The data from a global 
study show that the number of DM patients in 2011 has reached 366 million people, and is 
predicted to increase to 552 million by 2030. In 2006, more than 50 million people in Southeast 
Asia was recorded to suffer from DM. Based on the reports from the International Diabetes 
Federation (IDF) 183 million people are not aware of suffering from DM. The other research 
finding reports that 80% of people with DM live in low and middle income countries, and most 
of people with diabetes were 40 to 59 years old [1].   
In overcoming DM problems, drugs serve only as a complement to the diet because it only 
needs to be given if the maximal diet formulation cannot control the blood sugar level. Oral 
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anti-diabetic drugs may be needed for people with diabetes who are allergic to insulin or who do 
not use insulin injections. Drug usage should be well controlled in order to have the right dose 
adjustment with its indication, without causing hypoglycemia. Over-consumption of anti-
diabetic drugs has undesirable side effects, so experts develop a safer anti-diabetic traditional 
treatment system. 
Antioxidants are chemical compounds that can contribute one or more electrons to free radicals, 
so that the free radicals can be muted [2]. Based on the source of acquisition, antioxidants are 
divided into two: natural and artificial antioxidants (synthetic) [3]. The human body does not 
have antioxidant reserves in excess amount, so if there is excessive radical exposure then the 
body will require exogenous antioxidants. Due to the concerns about the possible unknown side 
effects of synthetic antioxidants, natural antioxidants are a much-needed alternative [4], [5]. 
Natural antioxidants are capable of protecting the body against damage caused by reactive 
oxygen species, inhibiting the occurrence of degenerative diseases and inhibiting lipid peroxide 
in food. Therefore, the research interest in natural antioxidants has been increasing in recent 
years [5]. 
Yam bean (Pachyrizus spp.) is a horticultural crop that has excellent potential to be developed 
because it has numerous benefits: (1) its tubers contain inulin that cannot be digested so that it 
can be used as a substitute for sugar, (2) its starch content can be used as a cosmetic ingredient, 
(3) it can be used as the basic ingredient of medicine for cancer, diabetes mellitus, abdominal 
pain and (4) it can be processed as food.  
A survey done by Suzuki in 1998 showed that the low mortality from coronary heart disease, 
breast cancer, uterine cancer and atherosclerosis was influenced by high levels of soy-based 
foods consumption such as tofu, natto, miso and milk. Such low mortality is presumably due to 
the role of soy isoflavones, including genistein, daidzein and glycitein, which have biological 
activities as phytoestrogens and antioxidants [6]. 
It has been proved that the benefits of soy-yamgurt from yam bean extract containing water-
soluble polysaccharide (WSP) known as inulin and soybean extract which contains many 
antioxidants, fiber and other nutrients can be increased by processing it into yogurt containing 
live lactic acid bacteria in digestion. This characteristic is very useful for people with diabetes or 
people who do low-calorie diet [7].  
The existence of isoflavones and WSP, fibers, lactic acid bacteria add to the prestige of yam 
bean and soybean as the plants beneficial for health. Isoflavones can serve as antioxidants, so 
they are useful for preventing: (1) oxidative damage of cell membranes, (2) atherosclerosis due 
to oxidation of LDL (bad cholesterol), (3) coronary heart disease, (4) cardiovascular disease, 
and (5) oxidative damage of DNA. In addition, the antioxidant power of isoflavones is also 
useful to provide antiproliferative effects and inhibit the growth of melanoma cells (one of the 
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triggers of cancer) [6], while WSP is useful for the health of flora living in the intestine such as 
Lactobacillus sp. [7]. 
Soy-yamgurt is a fermentation product of yam bean extract and soybean extract made by adding 
Lactobacillus bulgaricus bacteria and Streptococcus thermophillus bacteria. Soy-yamgurt is 
expected to maximize the utilization of soybean and yam bean as well as to increase its 
nutritional value. Soy-yamgurt is relatively more durable than fresh milk or powdered milk 
dissolved in water, but it must be stored in a cold place to maintain its quality for several days. 
Yam bean extraxt contains flavonoids compounds, phenol compounds and other compounds 
that have antioxidant potency, so it can serve as an antidote to free radicals; however, its 
potential has never been explored. Therefore, a test for antioxidant activity of soy-yamgurt 
probiotics has been carried out and the results showed that soy-yamgurt probiotics have a strong 
IC50, just like those of vitamin C and synthetic BHT antioxidants. 
2. Materials and Method 
The materials used were tubers of yam bean of elephant varieties with 5 months of harvest age 
obtained from the plantation area in Tanah Seribu of Binjai, North Sumatra and soybean of 
Anjasmoro varieties obtained from traditional markets in Medan, North Sumatra. Several other 
materials were sugar (Gulaku), skim milk (Prolac), mineral water, arabic gum and Bio-kul 
yogurt starter bacteria (Streptococcus thermophilus, Lactobacillus bulgaricus, and Lactobacillus 
acidophilus). The reagents used in this research were MRSA (deMan Rogosa and Sharpe Agar), 
ethanol, aquadest, 96% alcohol, DPPH (2.2-diphenyl-1-picrylhydrazyl), NaOH (sodium 
hydroxide), hexane solvent, concentrated H2SO4 (sulfuric acid), NaCl (sodium chloride), 
C6H12O6 (glucose), streptozotocin (Bioworld), nicotinamide, and buffer at pH 4.5. The animal 
experiments were 30 ten to sixteen week old white Wistar rats with 160 to 200g weight. 
The research was conducted in five stages. The first stage was making yogurt starter. The 
second stage was making yam bean extract. The third stage was making soybean extract. The 
fourth stage was making soy-yamgurt. The fifth stage was in-vivo testing on the rats with 4 
parameters: weight weighing, hypoglycemic effect test, glucose tolerance, and in situ glucose 
absorption using inverted intestine using two factors of randomized factorial design (RFD). The 
first factor of the treatment was done through 5 levels of treatment: P1 = The control group was 
given aquadest for 31 days; P2 = The negative group was given nicotinamide of 230 mg/kg 
body weight and streptozotocin of 65 mg/kg body weight for 3 days, and was then given 
aquadest for 28 days; P3 = The positive group was given nicotinamide of 230 mg/kg body 
weight and streptozotocin of 65 mg/kg body weight for 3 days, and was then given 
glibenclamide of 0.45 mg/kg body weight for 28 days; P4 = The experimental group was given 
streptozotocin of 65 mg/kg body weight and nicotinamide of 230 mg/kg body weight for 3 days, 
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and was than given soy-yamgurt of 3ml/head for 28 days; and P5 = The experimental group was 
given nicotinamide of 230 mg/kg body weight and streptozotocin of 65 mg/kg body weight for 
3 days, and was then given soy-yamgurt of 3.5 ml/head for 28 days. The second factor was the 
time of glucose level observation consisting of 4 stages: W1 (the 1st week), W2 (the 2nd week), 
W3 (the 3rd week) and W4 (the 4th week). 
2.1. Yoghurt Starter Making 
16 g of skim milk powder added by 3% of sugar was dissolved with 100 ml of hot water and 
then the temperature was lowered to 45 °C. After that, the commercial yogurt starter culture 
(biocule plain) was added as much as 5% of the mixture volume and was stirred. Then the 
mixture was covered with polyethylene plastic and was perforated using a needle. Next, it was 
incubated at 40-45 °C for 6 hours. Pasasi was conducted 3 times. The resulting yogurt starter 
was stored in a refrigerator with a temperature of 4 °C, on an anaerobic condition. 
2.2. Yam Bean Extract Making 
The tuber of yam bean was cleaned and put in a juicer. It was added by water with the ratio of 
yam bean and boiled water of 1:1. The result of juicing process was filtered using a filter cloth 
which has been blanched, and the extract was then taken out. 
2.3. Soy Milk Making 
The soybeans were sorted and soaked, then they were boiled twice (30 minutes for each), i.e. 
before and after the immersion of 0.2 % of NaHCO3 (sodium bicarbonate) solution within 30 
minutes. The soybean hull was then separated by squeezing and washing it with water many 
times for the easy process of hulling. The hull-less soybeans were given hot water (100 °C) with 
the ratio of soybeans to hot water of 1: 6 and then they were ground or blended. The soybean 
powder was filtered with a filtered cloth which has been blanched and the soy milk was left on a 
low heat for 20 minutes at a temperature of 80°C. 
2.4. Soy-Yamgurt Making 
Soy-yamgurt was made from soy milk and yam bean extract with the ratio of 50%:50%, then it 
was added by skim milk powder (15%) and sugar (2%), and was inoculated with the addition of 
starter (3%) and mixed with the arabic gum (0.6%). Furthermore, the incubation process was 
carried out by closing the mixture using perforated polyethylene plastic. The incubation was 
carried out at a temperature of 40±2°C for 6 hours. The soy-yamgurt that has been formed was 
stored in the refrigerator with a temperature of 4°C, anaerobic conditions. 
2.5. In-Vivo Testing 
In-vivo bioassay was carried out to determine the potential of soy-yamgurt in lowering blood 
sugar levels in diabetic conditions. The tests for soy-yamgurt were performed as follows: 30 
Wistar rats were put in a collective cage with room temperature of 20-25 °C. The rats were fed 
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in ad libitum. All the rats were adapted for one week before the treatment was given. The 
experiment was carried out for 28 days, and the weight and blood sugar level of the rats were 
analyzed every week. The rats were divided into 5 groups: control, positive, negative, and 
experimental groups. Each group consisted of 6 rats. 
Soy-yamgurt was given daily for 28 days in force feeding with a dose of 3 ml/head and 
3.5ml/head. Streptozotocin induction was performed after 15 minutes of nicotinamide 
administration and was used to induce diabetes (hyperglycemia). Before the induction process, 
the rats had been given 1 week adaptation. Three days after the injection of streptozotocin, the 
rats’ blood was taken through the tail and was measured with a glucometer to ensure that the 
rats were in hyperglycemic conditions. Before the blood was taken, the rats were fasted for 16 
hours. Only were rats with fasting blood glucose levels of more than 126 mg/dl used. The 
analysis on the rats was realized in hypoglycemic effect testing [8], weight weighing, glucose 
tolerance [9] and in situ glucose absorption test with reversed intestine sac. 
3. Results and Discussion 
3.1. Chemical Characteristics of Soy Milk and Soy-yamgurt  
Soybean is a commodity that has good source of nutrition, especially protein, because its amino 
acid structure almost resembles animal protein [10]. One of its processed products is soy milk. 
The chemical characteristics of soy milk can be seen in Table 1. 
Table 1. Chemical Characteristics of Soy Milk 
Parameters Analysis Results 
Water content (% wb) 89.1847±0.1048 
Ash content (% db) 0.3351±0.2478 
Protein content (% db) 4.4538±0.0067 
Fat content (% db) 2.2299±0.2076 
Fiber content (% db) 0.7763±0.0998 
Notes: The test was done twice, the (±) mark indicates standard deviation value 
The test of soy-yamgurt included chemical and phytochemical characteristics based on the water 
content, total solids, protein content, total lactic acid, viscosity, lactic acid bacteria, fiber 
content, antioxidant activity, total phenolic, and total flavonoids. The chemical characteristics of 
soy-yamgurt can be seen in Table 2. 
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Table 2. Chemical and Functional Characteristics of Soy-yamgurt 
Parameters Analysis Results 
Water content (%) 0.9777±0.1433 
Total solids (%) 18.8527±0.2693 
Protein content (%) 11.9495±0.9283 
Total lactic acid (%) 1.0284±0.0250 
Viscosity (pa.s) 20.5656±2.2002 
Lactic acid bacteria (log CFU/g) 10.2216±0.0644 
Fiber content (%) 0.9783±0.0124 
Notes: The test was done twice, the (±) mark indicates standard deviation value  
3.2. Phytochemical Characteristics of Yam Bean Extract, Soy Milk and Soy-yamgurt 
The results of testing the antioxidant activity (IC50), total phenol and total flavonoids in yam 
bean extract, soy milk and soy-yamgurt can be seen in Table 3. 
Table 3. Antioxidant Activity, Total Phenol and Total Flavonoids in Yam Bean Extract, Soy 
Milk, and Soy-Yamgurt  
Parameters IC50 (μg/ml) 
Total Flavonoids 
(μgQE/g) 
Total Fenol 
(μgGAE/g) 
Yam bean extract 40.5379 892.4927 956.8532 
Soy milk 41.6981 1,574.0026 791.7033 
Soy-yamgurt 44.9925 1,345.7266 711.8978 
From the data analysis, it is found that the average IC50 values of yam bean extract, soy milk, 
and soy-yamgurt were 40.5379 μg/ml, 41.6981 μg/ml and 44.9925 μg/ml, respectively. Based 
on the antioxidant activity strength table, yam bean extract, soy milk, and soy-yamgurt were 
among the strongest parameters because their IC50 values were below 50 ppm. The lower the 
value of IC50 was obtained the higher the antioxidant activity would be. 
3.3. In Vivo Test to Rat Experiments 
The result of the in vivo test that has been done on the rats showed that the treatment in each 
group of rats had highly significant different effect (P <0.01) on the hypoglycemic effect and 
had a significant effect (P <0.05) on the glucose absorption.  
3.4. Hypoglycemic Effect of Soy-yamgurt 
Blood glucose level is one of the parameters of diabetes condition. The type of treatment and 
periodic time of fasting blood glucose testing and their interactions had a highly significant 
different effect (P<0.01). Types of treatment gave a very significant different effect (P<0.01) on 
the percentage of the decrease of fasting blood glucose levels of the rats. 
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Notes: P1 = Control Group; P2 = Negative Group (+ streptozotocin-nicotinamide); P3 = 
Positive Group (+ streptozotocin-nicotinamide and glibenclamide); P4 = Experimental Group 1 
(+ streptozotocin-nicotinamide and 3 ml of soy-yamgurt); P5 = Experimental Group 2 (+ 
streptozotocin-nicotinamide and 3.5 ml of soy-yamgurt) 
Figure 1. Relation of Types of Treatment to Fasting Blood Glucose Level of Rats 
 
Figure 1 shows that the effect of P2 treatment (negative group) had the highest fasting blood 
glucose level at 136.92 mg/dL and the lowest one was found in the effect of P1 treatment 
(control group) at 96.25 mg/dL. In addition, Figure 1 also shows that after the 28 day test 
period, the rats in the P2 treatment (negative group) were still in diabetic condition, while in the 
P3 treatment (positive group), P4 treatment (experimental group treated with 3 ml of soy-
yamgurt), and P5 (experimental group treated with 3.5 ml of soy-yamgurt) the rats has returned 
to normal condition. The rats with P2 treatment (negative group) experienced a diabetic 
condition with fasting blood glucose levels at 136.92 mg /dL due to the induction of 
streptozotocin and the absence of alternative therapies that might cause damage to pancreatic β-
cells and disruption to the insulin’s work resulting in the increased levels of blood glucose in the 
rats. In this case, it has been proven that stz was able to cause diabetic condition to animal 
experiments. This finding is in line with the research done by Erwin [11] who found that 
streptozotocin can drive animals into a diabetic condition due to the formation of highly reactive 
free radicals that can cause damage to pancreatic β-cell membrane, protein, and DNA as they 
cannot produce insulin to convert glucose into glycogen. 
Figure 1 shows the rats treated with P4 treatment and P5 treatment had fasting blood glucose 
levels close to the rats with P1 treatment (control group) and P3 treatment (positive group). 
Within 28 days, the fasting blood glucose levels of rats with P4 treatment (experimental group 
with 3 ml of soy-yamgurt) returned to the normal condition at 110.83 mg/dL and in the P5 
treatment (experimental group with 3.5 ml of soy-yamgurt) the fasting blood glucose levels of 
rats also returned to the normal condition at 107.33 mg/dL, with the restriction of fasting blood 
glucose levels of rats with diabetes at more than 126 mg/dL. 
The administration of soy-yamgurt in the experimental groups (P4 and P5) indicated that the 
performance of polysaccharides and antioxidants found in the soy-yamgurt was able to 
counteract free radicals and reduce oxidative stress resulting in the capability of lowering blood 
glucose levels. This finding is in line with the statement of Retnaningsih, et al. [12] that 
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flavonoids can increase the activity of superoxide dismutase (SOD) antioxidants in rats so that it 
can reduce the destruction of pancreatic β-cells and the insulin performance is relatively good 
enough. Besides, the decreased blood glucose levels are increasingly obvious to a certain extent. 
 
 
Figure 2. The Relationship of Periodic Test With Fasting Blood Glucose Levels in the Rat 
 
ExperimentsThe average fasting blood glucose level of rats at the 1st week was 128.67 mg/dL 
which was the highest fasting blood glucose level, and the longer the testing time was the lower 
the fasting blood glucose level would be. This was because streptozotocin-nicotinamide still 
worked at the 1st week and 2nd week. After the 3rd week, the antioxidants in soy-yamgurt played 
their role in preventing free radicals and reducing oxidative stress so that they could lower the 
blood glucose levels. This finding is in line with the statement of Retnaningsih, et al. [12] that 
flavonoids can induce the activity of superoxide dismutase (SOD) antioxidants in rats so that it 
can reduce the damage of pancreatic β-cells resulting in the decrease of blood glucose levels.  
The sharpest decrease in blood glucose levels was found in the P3 treatment (positive group), 
i.e. the induction of stz-na and the administration of 0.45 mg/kg bb of glibenclamide. The sharp 
decrease was also experienced by the rats in P4 and P5 (experimental group), i.e. the induction 
of sth-na and the administration of 3 ml and 3.5 ml of soy-yamgurt. 
 
 
Figure 3. Relationship of Types of Treatment and Periodic Test Against Fasting Blood Glucose 
Levels of Rats 
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Figure 3 shows that the blood glucose levels of hyperglycaemic rats on P4 treatment and P5 
treatment returned to the normal condition (<126 mg/dL) after the administration of soy-
yamgurt for 28 days. The administration of soy-yamgurt in the experimental group of P4 and P5 
indicated the performance of antioxidants in soy-yamgurt that could counteract free radicals and 
functioned as the inhibitors of α-glucosidase enzymes that could lower blood glucose levels. 
This finding is in accordance with the statement of Havsteen [13] that the function of flavonoids 
is to inhibit the activity of the α-glucosidase enzyme thus delaying glucose uptake and 
potentially lowering blood sugar levels. The α-glucosidase enzyme inhibitor is a potential agent 
used for DM therapy. The inhibition of α-glucosidase enzyme activity might work in inhibiting 
polysaccharide breakdown in the small intestine so that the absorbable monosaccharide was 
reduced and, at the same time, the increase in the post-prandial blood glucose levels of diabetics 
could be inhibited [14]. 
Table 4. Effect of Types of Treatment on the Percentage of the Change of rat Blood Glucose 
Level Within 28 Days 
Group 
Blood glucose levels (mg/dL) Percentage of blood 
glucose level changes (%) Initial Final 
P1 124.0000±  2.6458 100.0000±5.1962 19.3893±2.5539 
P2 130.6667±  1.1547 135.0000±6.2450 -3.3139±4.6336 
P3 128.0000±  1.0000 78.3333±3.0551 38.7874±2.8539 
P4 133.0000±  4.3589 74.0000±5.0000 44.3878±2.5296 
P5 143.6667±11.2398 72.3333±3.2146 49.5505±2.2443 
Notes: The test was administered three times, the (±) mark indicates the standard deviation 
value;  (+) = decreased blood glucose levels; (-) = increased blood glucose levels; P1 = Control 
Group; P2 = Negative Group (+ streptozotocin-nicotinamide); P3 = Positive Group (+ 
streptozotocin-nicotinamide and glibenclamide); P4 = Experimental Group 1 (+ streptozotocin-
nicotinamide and 3 ml of soy-yamgurt); P5 = Experimental Group 2 (+ streptozotocin-
nicotinamide and 3.5 ml of soy-yamgurt)  
Table 4 shows that the administration of 3 ml or 3.5 ml of soy-yamgurt had the effect of 
lowering blood sugar levels. The administration of 3.5 ml of soy-yamgurt had a greater 
percentage of decrease in fasting blood glucose levels when compared with a dose of 3 ml. This 
was because the higher the dose was administered the higher the number of oligosaccharides 
and antioxidant activities that worked in preventing free radicals would increase. In addition, the 
difference in the percentage of decrease in blood glucose levels was assumed to be caused by 
the amount of the intake of oligosaccharides into the gastrointestinal tract, so that the higher the 
doses were administered the more amount of intake of oligosaccharides would come in [15]. 
Figure 4 shows that after 28 days, the P2 group of rats (negative group) experiences an increase 
to the above normal blood glucose levels, indicated by a negative percentage; meanwhile, the P3 
group (positive group), P4 group and P5 group experienced a decrease in blood glucose levels 
characterized by a positive percentage. 
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Figure 4. Relationship of Effect of the Types of Treatment to the Percentage of Changes in the 
Fasting Blood Glucose Level of Rats (mg/dL) Within 28 Days 
 
The rats with P2 treatment experienced an increase in blood glucose levels due to the absent 
administration of alternative therapies and were given only regular food so that the stz 
administered caused the increase in blood glucose levels presumably due to damage to 
pancreatic β-cells leading to disruption in the way the insulin worked. 
Figure 4 shows that the rats in the experimental groups (P4 and P5) experienced decreased 
blood glucose levels, i.e. 44.39% and 49.55%, respectively. After being treated for 28 days, the 
experimental group experienced a decrease in blood glucose levels caused by the activity of 
antioxidant compounds and oligosaccharides in soy-yamgurt that had hypoglycemic effects. 
This finding is consistent with Rudrappa [16] stating that inulin cannot be directly broken down 
into sugars, inulase enzyme is needed for the solution, which will then be fermented in the 
intestines. In the soybeans are isoflavones compounds which are phytoestrogens acting as the 
antioxidants that can inhibit the oxidation of glucose [17]. Water-soluble fiber can delay and 
reduce blood glucose levels by increasing food transit times in the small intestine, delaying 
gastric emptying and slowing down glucose absorption [18]. 
3.5. The In Situ Glucose Absorption Test Uses an Inverted Intestine Sac 
The types of treatment and the effect of the test time had highly significant effect (P<0.01) on 
glucose level in the rats’ inverted intestine test, while the interaction between the two had no 
significant effect (P>0.05). 
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Notes: P1 = Control Group; P2 = Negative Group (+ streptozotocin-nicotinamide); P3 = Positive 
Group (+ streptozotocin-nicotinamide and glibenclamide); P4 = Experimental Group 1 (+ 
streptozotocin-nicotinamide and 3 ml of soy-yamgurt); P5 = Experimental Group 2 (+ 
streptozotocin-nicotinamide and 3.5 ml of soy-yamgurt) 
Figure 5. Relationship of the Types of Treatment to the Absorption of Glucose  
in Inverted Intestine of Rats 
 
Figure 5 shows that the experimental group of P4 and P5 had glucose levels approaching the P1 
treatment (control group) while the P2 treatment (negative group) had low glucose level. This 
indicated that the intestines of the negative group of rats (positive for diabetes) had digested 
almost all of the 20% glucose solution administered; meanwhile, in the P4 and P5 experimental 
groups, 10% of soy-yamgurt administration was relatively higher than P2. This was because the 
WSP in soy-yamgurt had been degraded into short chain fatty acids by microbes in the intestine 
with the help of enzymes. Short-chain fatty acids produced might inhibit blood glucose because 
WSP with a unique chemical structure could not be digested by digestive enzymes. 
According to the literature of Ministry of Health of the Republic of Indonesia [14], the activity 
of α-glucosidase enzymes such as maltase and sucrose in hydrolyzing oligosaccharides to 
glucose, fructose and other monosaccharides in the small intestinal wall can be inhibited by the 
α-glucosidase inhibitor compound, one of which is flavonoids. The inhibition of this enzyme 
activity is effective in reducing the digestion of carbohydrate and its absorbs process in the 
small intestine so as to decrease the post prandial blood sugar level of diabetes mellitus. This 
medicinal compound affects only a decrease in blood sugar levels at mealtimes and does not 
affect blood sugar levels thereafter. The α-glucosidase inhibitor may also inhibit the activity of 
the α-amylase enzyme in the hydrolysis of polysaccharides in the intestinal lumen. 
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Figure 6. Relationship of Periodic Test With the Absorption of Glucose  
in the Inverted Intestine of Rats 
 
Figure 6 shows that the T1 treatment (10 minutes) had a glucose level of at least 1.54 mg/100 g 
of the ingredients, and the T4 treatment (40 minutes) had the highest glucose level at 2.89 
mg/100 g of the material. This suggests that, at the 10th minute test, all of the 20% of glucose 
solution administered could be absorbed because the administered soy-yamgurt had not reacted 
and had not been degraded by the microbes in the intestine. The longer test duration made the 
absorption of glucose in the intestine inhibited because hydrolyzing oligosaccharides in soy-
yamgurt has been inhibited by α-glucosidase inhibitor compounds. 
4. Conclusion 
The experimental group (P5), i.e. the nicotinamide induction of 230 mg/kg body weight, 
streptozotocin of 65 mg/kg of body weight and 3.5 ml of soy-yamgurt were the rats 
experiencing the most significantly decreased blood glucose level (P <0.01) compared to other 
treatment groups. The administration of 3.5 ml of soy-yamgurt could significantly (P<0.01) 
lower the blood glucose levels after 4 weeks (28 days) in the streptozotocin-nicotinamide 
induced rats. 
The mechanism of lowering blood glucose levels by water-soluble polysaccharides (WSP) was 
related to the nature of the WSP for its capability of forming a gel in the digestion that could 
slow stomach emptying, accelerate transit time in the small intestine, control glucose absorption 
in the blood and serve as a prebiotic to decrease the blood glucose levels. 
10% of soy-yamgurt was able to inhibit the absorption of glucose in the small intestine of the 
rats in the experimental group, while the small intestine of the rats in the negative group could 
not inhibit the glucose administered. This was because the oligosaccharides found in soy-
yamgurt could form gel and could be degraded into short chain fatty acids by microbes with the 
help of enzymes. The short-chain fatty acids produced could inhibit blood glucose so that less 
absorption occurred. 
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